|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 107.42 USD | -0.04% |
|
+1.34% | +35.23% |
| 07-17 | CVS Health Opens Pharmacy-Focused Location in Houston | MT |
| 07-17 | Cvs Health Unveils First Pharmacy-Focused Cvs Pharmacy Location in Houston | CI |
| Market Cap | 137B 120B 111B 102B 193B 13,223B 196B 1,328B 521B 6,470B 515B 504B 22,291B | P/E 2026 * |
17.1x | P/E 2027 * | 14.9x |
|---|---|---|---|---|---|
| Enterprise Value | 193B 169B 156B 144B 271B 18,605B 276B 1,869B 733B 9,103B 724B 709B 31,363B | EV / Sales 2026 * |
0.47x | EV / Sales 2027 * | 0.44x |
| Free-Float |
71.2% | Yield 2026 * |
2.47% | Yield 2027 * | 2.55% |
Last Transcript: CVS Health Corporation
| 1 week | +1.34% | ||
| Current month | +3.74% | ||
| 1 month | +5.94% | ||
| 3 months | +40.14% | ||
| 6 months | +34.00% | ||
| Current year | +35.23% |
| 1 week | 103.56 |  | 108.97 |
| 1 month | 99 | | 108.97 |
| Current year | 69.51 | | 108.97 |
| 1 year | 58.5 | | 108.97 |
| 3 years | 43.56 | | 108.97 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
Ali Keshavarz
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/26/26 | Tax | Controller/Auditor | -454 | 0.0000% | ||
| 5/31/26 | Tax | Chief Technology Officer | -7,618 | 0.0006% | ||
| 5/31/26 | Tax | Chief Financial Officer | -2,478 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.04% | +1.34% | +74.11% | +43.34% | 137B | |
| -0.04% | -5.35% | +1.45% | +28.90% | 82.34B | |
| +3.04% | +3.14% | +5.50% | +52.92% | 26.9B | |
| -2.10% | +0.33% | +24.98% | +44.87% | 23.32B | |
| +0.61% | +0.23% | -15.10% | -28.90% | 19.94B | |
| +0.47% | -0.06% | +11.47% | +146.69% | 16.79B | |
| -0.50% | +0.62% | +8.36% | +7.25% | 15.38B | |
| -0.41% | +0.49% | +69.79% | +124.41% | 15.21B | |
| +0.07% | -1.56% | -6.54% | -14.31% | 12.84B | |
| +1.12% | -0.56% | -9.40% | +80.14% | 11.01B | |
| Average | +0.33% | -1.07% | +16.46% | +48.53% | 36.09B | |
| Weighted average by Cap. | +0.18% | -1.03% | +32.99% | +42.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 409B 359B 332B 305B 576B 39,480B 585B 3,966B 1,555B 19,317B 1,537B 1,504B 66,553B | 427B 374B 346B 318B 600B 41,147B 610B 4,134B 1,620B 20,133B 1,602B 1,567B 69,364B |
| Net income | 8.04B 7.05B 6.52B 5.99B 11.31B 776B 11.49B 77.94B 30.55B 380B 30.21B 29.55B 1,308B | 9.35B 8.19B 7.57B 6.96B 13.14B 901B 13.35B 90.54B 35.49B 441B 35.1B 34.33B 1,519B |
| Net Debt | 55.81B 48.92B 45.22B 41.59B 78.47B 5,382B 79.73B 541B 212B 2,633B 210B 205B 9,072B | 52.23B 45.78B 42.32B 38.92B 73.43B 5,037B 74.61B 506B 198B 2,464B 196B 192B 8,490B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | US$107.55 | +0.07% | 3,014,859 |
| 26-07-17 | US$107.47 | +0.91% | 6,608,659 |
| 26-07-16 | US$106.50 | +0.56% | 12,025,143 |
| 26-07-15 | US$105.91 | -0.25% | 6,939,634 |
| 26-07-14 | US$106.18 | +0.26% | 11,396,143 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
